Search - tctmd.com

Displaying 1 - 20 of 55

Sort: Relevancy | Date

Presentation TCT 2025

First Report of the SPYRAL AFFIRM Study: Reduced Home and Office Blood Pressure Following Radiofrequency Renal Denervation in a Large US Cohort of High Cardiovascular Risk Patients.

Presenter: Felix Mahfoud

October 27, 2025

Presentation TCT 2025

TCT 591: High Diastolic Blood Pressure as a Predictor of Limitation of Cerebroprotective Effects of Renal Denervation

Presenter: Alla Falkovskaya

October 27, 2025

Presentation TCT 2025

TCT 588: 24-Month Durability of the Blood Pressure Lowering Effect of Ultrasound Renal Denervation for Hypertension with the Paradise System

Presenter: Ajay J. Kirtane

October 27, 2025

Presentation TCT 2025

TCT 431: Association of Fat Attenuation Index with Nighttime Blood Pressure and Prognosis

Presenter: Wei Gao

October 27, 2025

Presentation Fellows 2025

Welcome and Symplicity RDN Blood Pressure Procedure

Presenter: Sahil A. Parikh

May 16, 2025

Presentation THT 2025

Relationship Between Pulmonary Artery Diastolic Pressure and Blood Volume in Supine or Seated Positions

Presenter: Paula Rambarat

February 12, 2025

Presentation THT 2025

Relationship Between Changes in Pulmonary Artery Pressure, Blood Pressure and Weight in Response to Titration of Heart Failure Medications During Ambulatory Monitoring

Presenter: Sandip Zalawadiya

February 11, 2025

Presentation Controversies and Advances 2025

Cuffless blood pressure devices: Are they ready for prime time?

Presenter: Jennifer L. Cluett

January 30, 2025

Presentation TCT 2024

TCT 839: Optimal Blood Pressure Targets for Aortic Valve Replacement Patients

Presenter: Brennan Vogl

October 29, 2024

Presentation TCT 2024

TCT 486: Ultrasound Based Renal Denervation Reduces Blood Pressure in Patients With Chronic Kidney Disease: Results of a Multicenter Prospective Randomized Sham-Controlled Blinded Investigator Initiated Trial

Presenter: Roland Schmieder

October 28, 2024

Presentation TCT 2024

TCT 482: Anatomical Predictors for Blood Pressure Outcome After Endovascular Ultrasound Renal Denervation

Presenter: Karl Fengler

October 28, 2024

Presentation TCT 2024

TCT 480: Blood Pressure Reductions by Radiofrequency Renal Denervation Procedural Characteristics: Pooled 24-Month Results From the SYMPLICITY Clinical Program

Presenter: Felix Mahfoud

October 28, 2024

Presentation TCT 2024

TCT 1113: My STEMI Has No Pulse or Blood Pressure

Presenter: Aaron VanHise

October 27, 2024

Presentation ACC 2024

Effect of Alcohol-mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 3-month Primary Results From the Target BP I Randomized Trial

Presenter: David E. Kandzari

April 08, 2024

Presentation THT 2024

Blood Volume Profiles and Correlations with Pressures in Heart Failure with Impaired Renal Function

Presenter: Veraprapas Kittipibul

March 05, 2024

Presentation AHA 2023

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

Presenter: Jing Li

November 16, 2023

Presentation TCT 2023

TCT 145: Relationship Between Preprocedural Blood Pressure and Outcomes in Patients Undergoing Impella-Supported High-Risk PCI – Insights From the cVAD PROTECT III Study

Presenter: Guillaume Bonnet

October 26, 2023

Presentation TCT 2023

Backbeat Clinical Trial Program (Pacemaker-Mediated Blood Pressure Lowering)

Presenter: Daniel Burkhoff

October 25, 2023

Presentation TCT 2023

TCT 325: Changes in Blood Pressure after Crossover to Ultrasound Renal Denervation: Patient-Level Pooled Analysis of the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO and RADIANCE-HTN TRIO Trials

Presenter: Michael Bloch

October 25, 2023

Presentation TCT 2023

TCT 267: Pooled, 12-month Blood Pressure Reductions Using the Symplicity Spyral Radiofrequency Renal Denervation Catheter

Presenter: Felix Mahfoud

October 25, 2023

Advertisement

First Report of the SPYRAL AFFIRM Study: Reduced Home and Office Blood Pressure Following Radiofrequency Renal Denervation in a Large US Cohort of High Cardiovascular Risk Patients.

TCT 591: High Diastolic Blood Pressure as a Predictor of Limitation of Cerebroprotective Effects of Renal Denervation

TCT 588: 24-Month Durability of the Blood Pressure Lowering Effect of Ultrasound Renal Denervation for Hypertension with the Paradise System

TCT 431: Association of Fat Attenuation Index with Nighttime Blood Pressure and Prognosis

Welcome and Symplicity RDN Blood Pressure Procedure

Relationship Between Pulmonary Artery Diastolic Pressure and Blood Volume in Supine or Seated Positions

Relationship Between Changes in Pulmonary Artery Pressure, Blood Pressure and Weight in Response to Titration of Heart Failure Medications During Ambulatory Monitoring

Cuffless blood pressure devices: Are they ready for prime time?

TCT 839: Optimal Blood Pressure Targets for Aortic Valve Replacement Patients

TCT 486: Ultrasound Based Renal Denervation Reduces Blood Pressure in Patients With Chronic Kidney Disease: Results of a Multicenter Prospective Randomized Sham-Controlled Blinded Investigator Initiated Trial

TCT 482: Anatomical Predictors for Blood Pressure Outcome After Endovascular Ultrasound Renal Denervation

TCT 480: Blood Pressure Reductions by Radiofrequency Renal Denervation Procedural Characteristics: Pooled 24-Month Results From the SYMPLICITY Clinical Program

TCT 1113: My STEMI Has No Pulse or Blood Pressure

Effect of Alcohol-mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 3-month Primary Results From the Target BP I Randomized Trial

Blood Volume Profiles and Correlations with Pressures in Heart Failure with Impaired Renal Function

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

TCT 145: Relationship Between Preprocedural Blood Pressure and Outcomes in Patients Undergoing Impella-Supported High-Risk PCI – Insights From the cVAD PROTECT III Study

Backbeat Clinical Trial Program (Pacemaker-Mediated Blood Pressure Lowering)

TCT 325: Changes in Blood Pressure after Crossover to Ultrasound Renal Denervation: Patient-Level Pooled Analysis of the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO and RADIANCE-HTN TRIO Trials

TCT 267: Pooled, 12-month Blood Pressure Reductions Using the Symplicity Spyral Radiofrequency Renal Denervation Catheter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content